Netherlands Blood-based Biomaker For Sports Medicine Market Size & Outlook
Netherlands blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Netherlands blood-based biomaker for sports medicine market highlights
- The Netherlands blood-based biomaker for sports medicine market generated a revenue of USD 10.8 million in 2023 and is expected to reach USD 19.0 million by 2030.
- The Netherlands market is expected to grow at a CAGR of 8.4% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 10.8 million |
| Market revenue in 2030 | USD 19.0 million |
| Growth rate | 8.4% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Netherlands accounted for 1.6% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 86.6 million by 2030.
Ck was the largest segment with a revenue share of 18.52% in 2023. Horizon Databook has segmented the Netherlands blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
The rise in sports participation and injury incidence is expected to drive the demand for advanced diagnostic tools, pushing forward the development and application of blood-based biomarkers. As the market grows, these innovations are expected to improve athlete safety and optimize training & recovery protocols. According to NOC*NSF, the Netherlands has nearly 24,000 sports clubs with over 5 million members.
Remarkably, over 10 million Dutch citizens engage in some form of sport each week. The Dutch government is significantly investing in innovation within elite sports, focusing on advancements in training programs and competition formats. The 2022 MDPI report highlights that gym-based fitness activities accounted for 860,000 reported injuries, representing 16% of all sports-related injuries in the Netherlands. This substantial figure underscores the need for improved injury prevention and management strategies.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Netherlands blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Netherlands Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
